BackCelgene Overview

Celgene Current Assets

Track Celgene's current assets ($14B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$14.45B
↑ 84.67% YoYΔ $6.63B vs prior year quarter

Peer trimmed avg / median

Loading

Celgene Current Assets History

Loading

Celgene vs. peers: Current Assets Comparison

Loading

Celgene Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Celgene (CELG) FAQ

Celgene (CELG) currently reports a current assets of $14B as of September 2019. That compares with $7.8B in the prior-year period — up 84.7% year over year. Use the charts on this page to explore Celgene's current assets history and peer comparisons.

Celgene's current assets increased from $7.8B to $14B — a 84.7% year-over-year increase (period ending September 2019). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Celgene reported $14B in current assets as of September 2019. That compares with $7.8B in the prior-year period — up 84.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $14B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Celgene, and consider following CELG for alerts when major investors trade the stock.